Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Medical Imaging and Radiation Oncology|August 27, 2019
MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosisKoki Shimizu, Shunsuke Hamada, Tomohisa Sakai, et al.
World Neurosurgery|October 8, 2021
Diffusion-Weighted Magnetic Resonance Imaging Improves the Accuracy of Differentiation of Benign from Malignant Peripheral Nerve Sheath TumorsHiroshi Koike, Yoshihiro Nishida, Shinji Ito, et al.
Japanese Journal of Clinical Oncology|January 5, 2025
Selumetinib for symptomatic, inoperable plexiform neurofibromas in pediatric patients with neurofibromatosis type 1: the first single-center real-world case series in JapanYoshihiro Nishida, Norie Nonobe, Hiroyuki Kidokoro, et al.
International Cancer Conference Journal|January 8, 2024
Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcomaYao Liang, Osamu Maeda, Tomoya Shimokata, et al.
In Vivo (Athens, Greece)|October 31, 2023
Clinical Outcome in Patients With High-grade Soft-tissue Sarcoma Receiving Prosthetic Replacement After Tumor Resection of the Lower Extremities: Tokai Musculoskeletal Oncology Consortium StudyTomoki Nakamura, Tomohisa Sakai, Satoshi Tsukushi, et al.
Cancer Science|December 2, 2023
TGF-β signaling promotes desmoid tumor formation via CSRP2 upregulationYu Li, Teruaki Fujishita, Emi Mishiro-Sato, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 11, 2022
Hyaluronan in articular cartilage: Analysis of hip osteoarthritis and osteonecrosis of femoral headJiarui Zhang, Yoshihiro Nishida, Hiroshi Koike, et al.
Scientific Reports|July 13, 2022
Efficacy of auranofin as an inhibitor of desmoid progressionKan Ito, Yoshihiro Nishida, Shunsuke Hamada, et al.
Cancers|June 12, 2026
Clinical Outcome in Elderly Patients (Aged ≥ 65 Years) Treated with Chemotherapy for Advanced Soft Tissue Sarcomas: A Tokai Musculoskeletal Oncology Consortium StudyTomoki Nakamura, Satoshi Tsukushi, Akihito Nagano, et al.
Human Pathology|October 8, 2018
Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional studyHiroshi Koike, Yoshihiro Nishida, Kei Kohno, et al.
Pageof 5